Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection (Q45220298)

11 December 2017

Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection (English)

1 reference

11 December 2017

0 references

Human metapneumovirus

object named as

human metapneumovirus

1 reference

8

1 reference

11 December 2017

Rik L de Swart

1

0 references

Thijs Kuiken

series ordinal

3

object named as

Thijs Kuiken

1 reference

11 December 2017

5

Geert van Amerongen

1 reference

11 December 2017

6

Selma Yüksel

1 reference

11 December 2017

4

Sander Herfst

1 reference

11 December 2017

Bernadette G van den Hoogen

series ordinal

2

1 reference

PubMed ID

17996988

11 December 2017

Leo Sprong

series ordinal

7

1 reference

PubMed ID

17996988

11 December 2017

language of work or name

English

0 references

publication date

26 October 2007

1 reference

11 December 2017

1 reference

11 December 2017

25

1 reference

11 December 2017

51

1 reference

11 December 2017

8518-8528

1 reference

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Analysis of the genomic sequence of a human metapneumovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Human metapneumovirus as a major cause of human respiratory tract disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Clinical impact and diagnosis of human metapneumovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Adjuvants for human vaccines--current status, problems and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Immunopathogenesis of vaccine-enhanced RSV disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

A role for immune complexes in enhanced respiratory syncytial virus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Experimental infection of macaques with human metapneumovirus induces transient protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Antigenic and genetic variability of human metapneumoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Interleukin-13 in asthma pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Role of cytokines in allergic airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

A cautionary note on experimental artefacts induced by fetal calf serum in a viral model of pulmonary eosinophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

The innate signaling of dangers and the dangers of innate signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Friendly and dangerous signals: is the tissue in control?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

Live vaccines for human metapneumovirus designed by reverse genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.022

10.1016/J.VACCINE.2007.10.022

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

17996988